was conducted to determine the frequency of ophthalmologic, visceral, or cardiac involvement. Retinal abnormalities were observed in 4 (6%) of the 67 infants in whom indirect ophthalmoscopy examination was performed. Abdominal ultrasound abnormalities were detected in 5 (7.7%) of 65 infants. Echocardiogram revealed thrombi or vegetations in 11 (15.2%) of 72 infants. Age at onset, presence of central venous catheters, and species of Candida were not predictors for involvement at these sites. Infants with candidemia that lasted у5 days were more likely to demonstrate ophthalmologic, renal, or cardiac abnormalities than those with a shorter duration. Infants with involvement of these organs received larger cumulative doses of amphotericin B than those without detectable abnormalities. Because complication of disseminated candidiasis by eye, renal, or cardiac involvement has therapeutic implications, and because risk factors for candidemia inadequately predict these complications, evaluations are indicated for all neonates with candidemia.
diography, is recommended by some infectious disease specialists, but there is no consensus [4] . That endophthalmitis, obstructive nephropathy, and endocarditis are complications of disseminated candidiasis in the premature, low birth weight infant is well recognized [7] [8] [9] [10] . However, the frequency of these complications and the factors that may predict their presence are unknown. The objectives of this study were to determine the incidence of ophthalmologic, renal, and cardiac involvement during candidemia and to define potential predictors of their presence.
PATIENTS AND METHODS
The medical records of 106 infants hospitalized with invasive candidiasis in the Texas Children's Hospital NICU from January 1989 through June 1999 were retrospectively reviewed. Patients were identified by review of the culture database maintained in the hospital microbiology laboratory. We reviewed the medical records of infants from whom Candida species was isolated from any sterile site, including blood, CSF, peritoneal fluid, synovial fluid, and urine, or for whom there was histopathological evidence of invasive fungal dermatitis [11] with Candida species isolated from a skin biopsy specimen. Infants who had Candida isolated from at least 1 blood culture were included in this report. A standardized form was used to collect demographic, clinical, and laboratory information from the medical record of each patient. The extent of evaluation for disseminated disease was noted, and in particular whether ophthalmologic examination, abdominal ultrasound, or echocardiogram was performed. Infants in whom the diagnosis of disseminated candidiasis was established only postmortem were excluded. Infants had repeat blood cultures obtained daily until resolution of candidemia was documented. The duration of candidemia was defined as the number of days from the collection of the first blood culture that grew Candida to the last positive result of blood culture.
Continuous variables were analyzed using Student's t test or the Mann-Whitney U test according to distribution of data. Categorical variables were analyzed by Fisher's exact test. Twotailed alternatives were used for all calculations, and P ! .05 was considered significant. Statistical analysis was performed by SPSS for Windows, version 7.0.
RESULTS
During the 10-year study period, 110 infants admitted to the NICU developed invasive Candida infection. The medical records of 4 infants were not available for review. Seventeen patients had Candida isolated from a sterile site other than blood, including CSF ( ), urine collected by a sterile method n p 7 ( ), peritoneal fluid ( ), and synovial fluid ( ). n p 3 n p 5 n p 2 Three infants had the diagnosis established during postmortem examination. Infants who had definite or probable Candida meningitis are reported elsewhere [11] . A total of 86 infants had at least 1 blood culture that yielded Candida species, and these patients constitute the study population. Table 1 summarizes the demographic characteristics of the 86 neonates and factors associated with their candidemia. The median gestational age was 26 weeks; 78 (90.7%) infants were born at !35 weeks, 74 (86%) at !32 weeks, and 62 (72%) at !28 weeks of gestation. The median birth weight was 800 g. A total of 72 (83.7%) infants had birth weight !1500 g, and for 62 (72%), it was !1000 g. The median duration of antibiotic therapy before onset of candidemia was 12 days (range, 2-91 days). The proportion of days of life during which antimicrobials were administered ranged 6%-100% (median, 57%). The median duration of umbilical vessel catheterization was 7 days for arterial and 8 days for venous catheters. In those patients with nonumbilical central venous catheters (CVCs) before or at the time of candidemia, the catheter had been in place for a median of 20 days (range, 0-99 days).
CSF samples from 68 (79%) of the infants was examined, and Candida was isolated from the samples of 10 (14.7%). Urine obtained by suprapubic bladder tap or catheterization was cultured for 79 (92%) infants, and Candida was isolated from the samples of 21 (26.6%). Ten (11.6%) infants had Candida isolated from peritoneal fluid and 1 (1.2%) from synovial fluid. In 3 infants, there was evidence of invasive fungal dermatitis by histological examination [12] , and Candida was isolated from the culture of a skin biopsy specimen. Candida was isolated solely from the blood culture for 46 (53.5%) infants.
The Candida species isolated from the blood was C. albicans for 54 (62.8%) infants, C. parapsilosis for 26 (30.2%), C. glabrata for 3 (3.5%), and C. tropicalis, C. lusitaniae, and C. guillermondii for 1 infant each.
Evaluation of eyes, kidneys, or heart was performed for 81 (94.2%) of the 86 study infants. Of the 5 remaining patients, 4 died 2-5 days after the onset of candidemia. The remaining infant was a 196-day-old premature infant with CVC-associated candidemia who had prompt resolution of bloodstream infection after catheter removal. This infant had no evidence of disseminated candidiasis by physical examination or cultures of CSF and urine.
Indirect ophthalmologic examination was performed by an ophthalmologist in 67 (78%) infants. Eye involvement typical for Candida was detected in 4 (6%) infants. All but 8 of the ophthalmologic examinations were performed within 8 days of the onset of candidemia. Two infants had multiple scattered white chorioretinal lesions in both eyes, without evidence of involvement of the vitreous. Another infant presented with bilateral scattered retinal hemorrhages and Roth's spots; these abnormalities resolved late in the first week of antifungal therapy. The infant with endophthalmitis initially had a diagnosis of candidal chorioretinitis. He was treated with amphotericin B and flucytosine, but retinal lesion progression was noted, and involvement of the vitreous in the left eye occurred 13 days later. The infant underwent vitrectomy with intraocular administration of amphotericin B. Later ophthalmoscopy examinations demonstrated resolution of the infection with healing of retinal lesions.
Abdominal ultrasonography was performed for 65 (75.6%) infants. In 5 (7.7%), abnormalities attributed to disseminated candidiasis were evident. Three of these abnormalities were found in the kidneys, and 2 infants had liver lesions compatible with disseminated candidiasis. Renal abnormalities included unilateral dilation of the renal pelvis that contained echogenic soft tissue density in 1 infant and markedly increased echogenicity of both kidneys in 2 infants, one of whom also had a rounded echogenic mass within the bladder. Liver abnormalities included echogenic cystic structures within the parenchyma in 2 infants.
Seventy-two (83.7%) infants underwent echocardiography, and in 11 (15.3%), abnormalities were detected. Six infants had a thrombus in the superior or inferior vena cava as the only abnormality; 2 had increased echogenicity of the mitral valve, and 1 of these also had a thrombus in the left innominate vein. Vegetations in the left ventricle, vegetations in the left atrium, and echodense masses in both ventricles were observed in 1 infant each. Table 2 summarizes the demographics and clinical characteristics of infants who had abnormalities on examination of eye, abdomen, or heart. Only 1 infant had simultaneous involvement at 2 different sites (heart and kidney). Involvement of any of the end organs was present in 19 (23.5%) of 81 evaluated infants. Infants in whom abnormalities were noted were reevaluated to assess resolution of the lesions. Resolution of the lesions was noted in all infants who survived, except 5 of those with cardiac abnormalities, who had persistent but smaller vegetations or thrombi at the end of therapy.
The median duration of candidemia was similar in infants with abnormal and normal echocardiograms (5 vs. 4 days;
). Similarly, the median duration of candidemia in in-P p .19 fants with abnormalities on eye examination was not significantly different from the duration in those with normal results (5 vs. 4 days;
). Infants with abdominal ultrasound ab-P p .8 normalities were significantly more likely to have prolonged candidemia (median, 7 days) than those with normal imaging studies (median, 4 days; ). When infants in whom can-P p .02 didemia was documented for a single day were compared with those with infection for a longer duration, there were no statistical differences in frequency of abnormal examinations. However, infants with prolonged candidemia (positive blood culture results for у5 days) were significantly more likely to have abnormalities in one of the examinations compared with those with fungemia of shorter duration (36.8% vs. 10.4%;
). Isolation of Candida from a urine culture did not P p .008 predict abnormalities by renal ultrasonography. One-third of those with an abnormal study and 39% of those with a normal renal sonogram had Candida isolated from the urine. Similarly, the isolation of Candida from CSF was not associated with either retinitis ( ) or endocarditis ( ). P p .37 P p .5 The presence of an indwelling CVC at the time of candidemia was not associated with the presence of abnormalities by echocardiogram (17.5% vs. 14.2%, respectively, for those with and without a catheter;
). The median duration of candi-P p .74 demia was not different when infants who had a CVC at diagnosis were compared with those without a CVC (4 days in both groups;
). The CVC was removed from all patients P p .89 in whom it was present a median of 2 days (range, 0-8 days) after the blood culture that grew Candida species was collected. There was no association between duration of candidemia and time to removal of the CVC ( by linear regression anal-P p .16 ysis). In infants with a CVC and abnormalities by abdominal ultrasonography, the CVC tended to remain in situ longer (median, 4 days) than in those without these abnormalities (median, 2 days;
). There was no association between time P p .065 to removal of the CVC and the presence of ophthalmologic or echocardiographic abnormalities. The presence of simultaneous bacteremia and candidemia (defined as a blood culture yielding Staphylococcus aureus, Enterococcus, gram-negative bacilli, or at least 2 cultures that grew coagulase-negative staphylococci within 72 h before or after a blood culture that grew Candida species) was associated with a greater likelihood for an abnormal echocardiogram (35.2% vs. 9.2%;
). There was no P p .018 association between concomitant bacteremia and the presence of abnormalities by abdominal ultrasonography or indirect ophthalmoscopy examination.
Infants in whom abnormalities were detected by indirect ophthalmoscopic examination had a significantly greater gestational age at birth ( ) and corrected postconceptional P p .006 gestational age at onset of candidemia ( ) than did those P p .06 in whom no abnormalities were detected. There were no differences between the gestational age of patients who had abnormalities detected by echocardiography or abdominal ultrasonography compared to those in whom these studies were normal. The age at onset of candidemia was not associated with the development of any of these end-organ complications.
Because C. parapsilosis is believed to be less virulent than C.
albicans [13] , we compared the frequency of end-organ involvement in infants with infections caused by these 2 Candida species. Candidemia with either Candida species was as likely to be complicated by retinal, renal, or cardiac involvement in our patients. The number of patients with other Candida species was too small to permit a valid comparison. All infants were treated with iv amphotericin B deoxycholate. One of the patients with endocarditis and 2 of those with renal candidiasis were also treated with flucytosine (duration, 15, 5, and 27 days). The patient with endophthalmitis was treated with intraocular amphotericin B and flucytosine for 20 days in combination with iv amphotericin B. The mean cumulative doses of amphotericin B in survivors of systemic candidiasis were 32.5, 30.5, and 29.5 mg/kg for those with eye, abdominal, or cardiac involvement, respectively. Infants without these abnormalities were treated with a mean cumulative amphotericin B dose of 25.7 mg/kg. Each infant with ophthalmologic involvement had complete resolution of the infection and survived. Of the 5 infants with intra-abdominal complications, 1 died during the acute infection, and another, who had concomitant endocarditis, died after resolution of candidemia. Among the 11 infants with endocarditis, 3 died during the acute infection, and 2 died from causes unrelated to candidemia after completion of therapy. The overall mortality of the 19 infants with eye, intra-abdominal, or cardiac involvement was 31.5%, whereas mortality for the 67 without any of these findings was 26.4% ( ). The mortality rate attributable to Candida P p .77 infection, however, was 21.1% among infants with and 13.4% among infants without eye, abdominal, or cardiac complications of invasive candidiasis.
DISCUSSION
Candidemia is an increasingly recognized complication in premature infants with a prolonged NICU stay [1, 2] . Although it is acknowledged that there is a high frequency of disseminated infection in these infants, the frequency of involvement of different organs is unknown. Autopsy studies in adults and children with fatal candidiasis demonstrate dissemination to almost every organ [14] [15] [16] . However, findings in the patients who died, many of whom were not known to have systemic candidiasis before death, may not reflect the incidence of organ involvement early in the disease process.
The aim of this study was to establish the frequency of ophthalmologic, renal, or cardiac involvement in neonates with candidemia. We also attempted to determine whether specific risk factors would identify infants at higher risk for these complications. The abnormality most frequently found was in the cardiovascular system of the 86 infants we studied. Although there have been several case reports of Candida species endocarditis in neonates, the frequency of cardiac involvement is not known. Faix [17] reported only 1 neonate with endocarditis among 45 with invasive candidiasis, but echocardiography was not performed routinely in that study. Lee et al. [18] and Butler et al. [19] reported no cardiac abnormalities in the 10 and 19 infants, respectively, in whom echocardiography was performed. Endocarditis or thrombus was not associated with the duration of candidemia, the Candida species, or the presence of an indwelling CVC, but there was a significant association with concomitant bacteremia. However, 9.2% of the infants without concomitant bacteremia had abnormalities consistent with intravascular infection.
Therefore, although the presence of mixed bacterial and Candida bloodstream infection may be a marker for cardiac involvement, this association lacks sensitivity. The extent of fungal invasion in cardiac vegetations and thrombi cannot be accurately assessed in the absence of tissue samples. However, it is possible that both bacteria and Candida are pathogenic in the evolution of these lesions. It also is possible that the presence of a thrombus was unrelated to the process of infection. In a prospective study of neonates with CVCs, Tanke et al. [20] found abnormalities by echocardiography in 13% of infants. However, the presence of such abnormalities in premature infants with candidemia should raise concern for true infection, and treatment should consider this possibility. In an autopsy series of adult patients with disseminated candidiasis, Lipton et al. [15] reported that 80% of patients with cardiac involvement had concomitant CNS involvement. We did not find any association between isolation of Candida from CSF and abnormalities by echocardiogram. However, a CSF culture may not always identify the infant with CNS candidiasis, because CNS infection may involve parenchyma or meninges or both. Routine neuroimaging studies would be required to distinguish these alternatives [21] .
Renal involvement, including fungus ball uropathy and renal parenchymal infiltration, was described by Faix [17] in 26% of 45 infants with systemic candidiasis and in 33% of 30 candidemic infants reported by Benjamin et al. [22] . By contrast, only 7% of 14 infants reported by Lee et al. [18] had abnormalities detected by renal ultrasonography. In the 65 infants who we evaluated, renal involvement, as determined by ultrasonography, occurred in 4.6%. This variability in frequency may arise from methodological or demographic differences, as well as differences in the timing of ultrasonographic evaluations. For example, Bryant et al. [23] suggest that repeating renal ultrasonography later in therapy may detect abnormalities initially not discernible. A urine culture that yields Candida was found to be a poor predictor of abnormalities by renal ultrasonography. Baley et al. [24] also reported that the urine culture is an unreliable marker for renal involvement in neonates with disseminated candidiasis.
Ophthalmologic abnormalities in patients with candidemia vary, typically consisting of fluffy white lesions in the retina and the vitreous, retinal hemorrhages, Roth's spots, and uveitis [7, 25] . The literature reports wide variations in the incidence of ocular involvement in infants with invasive candidiasis (0%-44%) [17] [18] [19] 24] . Among the patients we studied, retinal involvement was found in 6% of infants in whom an evaluation was performed. These infants had a significantly greater gestational age than those without eye abnormalities. Mittal et al. [26] reported 22 candidemic neonates, and although none developed endophthalmitis, all but 1 developed retinopathy of prematurity. It is possible that retinal vascular compromise in infants that weigh !1500 g at birth has a protective effect against candidal retinitis and endophthalmitis. Alternatively, the inflammatory response in these immunologically immature premature infants may be such that characteristic retinal lesions may not be evident by examination, even when performed by an experienced ophthalmologist. Of note, 8 of the 15 infants we studied who did not have an ophthalmologic examination died shortly after the onset of candidemia; 2 of these were found to have disseminated candidiasis at autopsy. It is possible that a higher rate of ocular involvement may have been found if all patients had been examined. However, the critical condition of some patients precluded a complete evaluation.
The presence of a CVC at the onset of candidemia and time to removal of the CVC were not associated with prolonged fungemia or higher incidence of ophthalmologic, renal, or cardiac abnormalities. This may reflect the prompt removal of the CVC in the majority of patients, typically as soon as possible after documentation of yeast in the first blood culture (median of 2 days after collection of the blood specimen for culture). It is possible that failure to promptly remove a CVC prolonged candidemia and enhanced complications in a few infants, but this was not statistically verified in our case series.
The most appropriate therapy, drug, dose, and duration in neonates with candidemia is not known, because controlled clinical trials have not been reported [19, 27] . Evidence for disseminated candidiasis at any of the sites that were evaluated, however, is usually an indication for a prolonged course of amphotericin B deoxycholate [19, 28] . In those patients who received a complete course of therapy, the cumulative dose of amphotericin B administered tended to be high (∼30 mg/kg) when these complications were found. The overall mortality rate and the mortality attributed to Candida infection were not different in infants with documented eye, kidney, or cardiac involvement compared with those without these complications. Furthermore, no relapses were observed in the patients who completed therapy. Because few patients received flucytosine, its role in treatment was uncertain. Three infants with chorioretinitis were treated with iv amphotericin B alone, and the infant with endophthalmitis required intraocular amphotericin B administration and parenteral amphotericin B and orally administered flucytosine. Our findings appear to support a rec-ommendation for amphotericin B alone, without surgical intervention, in the treatment of candidal endocarditis [28, 29] . Whether a shorter course of amphotericin B therapy or alternative antifungal agents would have been associated with a comparable cure rate cannot be assessed without controlled, comparative trials.
In summary, ophthalmologic, intra-abdominal or cardiovascular involvement was documented in 20 (23.3%) of 86 candidemic premature infants who underwent evaluations for candidiasis at these sites. The age at onset of candidemia, presence of a CVC, and Candida species responsible for the infection were not predictors for involvement at any of these sites. Infants with prolonged candidemia were more likely to have evidence of Candida involvement of target organs, but even among those with only 1 positive result of blood culture, abnormalities were found. On the basis of our findings, we conclude that ophthalmologic, renal, and cardiac evaluations are indicated in premature neonates with candidemia because their detection may influence therapy and outcome.
